Hampel et al. (2018), studied the importance of six combined CSF biomarkers for the diagnosis of AD, including AB1-42, total-tau, phosphorylated tau, NFL, neurogranin and YKL-40 [26]. This evidence concerns the gene MAPT and Alzheimer disease.